Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-21-013331

Chief Financial Officer acquired 10,930 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-03-24 Exercise or conversion : show line 1 in the form +10,930 $2.48 $27,106 80,792 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-24 Exercise or conversion : show line 2 in the form Share Option (right to buy) −10,930 25,000 D
Loading xslF345X03/doc4.xml…